Israeli duo’s early Alzheimer’s detection test brings cure one step closer | The Times of Israel

Yes, but will it be in time to help Joe Biden?

TORONTO — Israeli expatriate biomedical engineers Eliav Shaked and Roy Kirshon may be far from old age but one of its dreaded curses — Alzheimer’s disease (AD) — figures prominently in their lives. As business partners in an artificial intelligence medical imaging start-up in Toronto called RetiSpec, they’ve developed a new way for early detection of AD, the main cause of dementia among older adults. In recent years, the World Health Organization has signaled the growing scourge of dementia (attributed mostly to AD) as a global epidemic. Tied, in part, to an aging population, an estimated 47 million people around the world now suffer from AD or related dementia.

Israeli duo’s early Alzheimer’s detection test brings cure one step closer | The Times of Israel